Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients | Zendy

Anita Rachlis | Zendy; Jonathan B. Angel | Zendy; Marianne Harris | Zendy; Richard Lalonde | Zendy; Fiona Smaill | Zendy; Cécile Tremblay | Zendy; Chris Tsoukas | Zendy; Sharon Walmsley | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients

Author(s) -

Anita Rachlis,

Jonathan B. Angel,

Marianne Harris,

Richard Lalonde,

Fiona Smaill,

Cécile Tremblay,

Chris Tsoukas,

Sharon Walmsley

Publication year - 2006

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 38

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/2006/402409

Subject(s) - enfuvirtide , human immunodeficiency virus (hiv) , medicine , virology , intensive care medicine , immunology , antigen , gp41 , epitope

An eight-member group consisting of Canadian infectious disease and immunology specialists and a family physician with significant experience in HIV management was convened to update existing recommendations, specifically intended for use by Canadian HIV-treating physicians, on the appropriate use of enfuvirtide in HIV/AIDS patients with resistance to other antiretroviral drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research